The Crowd Tape

What the street is doing, not what I think

What top X accounts are doing, not what I think

← Back to dashboard

AXTI

AXT, Inc.Small cap (market cap < $50B)Earnings 10/29Partly aligned
Close 51.47 (2026-10-16)28 days -26.5%1Y +1041.2%28 d mentions 2

Stance mix of tracked accounts 2 accounts mentioned it · latest post counts

BullishNeutralNo stanceBearish
Bullish
1
Neutral
1
No stance
0
Bearish
0
Accounts BullNeuBearNone
@aleabitoredditViews ›1000
@StockSavvyShayViews ›0100

Consensus and splits Reasons (analyst tagged) and views from the past 14 days

Bull case
  • 1Fundamentals
  • @aleabitoreddit: I think almost everything about my $AXTI thesis from 2025 was validated? From AXT's position in the InP substrate bottleneck... Being able to threaten the hyperscaler buildout (per Reuters)... $IQE has been flagging this as a major risk, VPEC and Taiwan epiwafer foundries have been crying over InP substrate bottlenecks. And there's even AXT direct confirmation of partnerships with $LITE and $COHR as the InP substrate supplier. AXT also stated $130m/quarter InP revenue capacity exiting 2027 (~$520m annualized) so that's a massive revenue inflection compared to previously. Now... the biggest question is: How much can AXT price hike? The substrates they make are just such a tiny part of the BOM... but can threaten hyperscaler buildouts with optics. So if they manage to price hike to $SNDK NAND degrees (which they can), then I think AXT could get re-rated a ton from here. But if they end up like Japanese ABF suppliers that are less willing to abuse their position, that's a different story. Will need to do more channel checks to see how that's coming along. But at the very least, I would argue there should be some valuation baseline just due to their critical importance (eg. upstream refinery ownerships, crucible processing, etc) + existing capacity revenue without hikes. TLDR: - Bottleneck thesis was at like ~$500m MC - Upside now comes from price hikes due to duopoly position + ownership of upstream bottlenecks in the InP substrate manufacturing process. (whi
Bear case
  • none

Partly aligned. No clearly opposing views so far.

Current views Each account’s latest stance and reasoning; change is vs that account’s previous call
Neutral First call
Basis not tagged · @StockSavvyShay lists the top 15 performers of 2026: $MRNA +639%, $SNDK +447%, $TWST +319%, $DELL +259%, $AXTI +215%, $MU +208%, $AEHR +200%, $PENG +192%, $MRVL +168%, $BE +155%, $AMD +147%, $INTC +143%, $LITE +124%, $OSCR +122%, $AAOI +117%.
2026-10-18 23:41 HKT Original post ↗
Bullish First call
Fundamentals · Medium term · I think almost everything about my $AXTI thesis from 2025 was validated? From AXT's position in the InP substrate bottleneck... Being able to threaten the hyperscaler buildout (per Reuters)... $IQE has been flagging this as a major risk, VPEC and Taiwan epiwafer foundries have been crying over InP substrate bottlenecks. And there's even AXT direct confirmation of partnerships with $LITE and $COHR as the InP substrate supplier. AXT also stated $130m/quarter InP revenue capacity exiting 2027 (~$520m annualized) so that's a massive revenue inflection compared to previously. Now... the biggest question is: How much can AXT price hike? The substrates they make are just such a tiny part of the BOM... but can threaten hyperscaler buildouts with optics. So if they manage to price hike to $SNDK NAND degrees (which they can), then I think AXT could get re-rated a ton from here. But if they end up like Japanese ABF suppliers that are less willing to abuse their position, that's a different story. Will need to do more channel checks to see how that's coming along. But at the very least, I would argue there should be some valuation baseline just due to their critical importance (eg. upstream refinery ownerships, crucible processing, etc) + existing capacity revenue without hikes. TLDR: - Bottleneck thesis was at like ~$500m MC - Upside now comes from price hikes due to duopoly position + ownership of upstream bottlenecks in the InP substrate manufacturing process. (whi
2026-10-10 21:46 HKT Original post ↗
Background How the narrative evolved over time, for context on current views

By week Last 4 weeks

  • 10/13–10/19 · 1 posts · Bull 0 / Bear 0
    @StockSavvyShay: @StockSavvyShay lists the top 15 performers of 2026: $MRNA +639%, $SNDK +447%, $TWST +319%, $DELL +259%, $AXTI +215%, $MU +208%, $AEHR +200%, $PENG +192%, $MRVL +168%, $BE +155%, $AMD +147%, $INTC +143%, $LITE +124%, $OSCR +122%, $AAOI +117%. (Neutral)
  • 10/6–10/12 · 1 posts · Bull 1 / Bear 0
    @aleabitoreddit: I think almost everything about my $AXTI thesis from 2025 was validated? From AXT's position in the InP substrate bottleneck... Being able to threaten the hyperscaler buildout (per Reuters)... $IQE has been flagging this as a major risk, VPEC and Taiwan epiwafer foundries have been crying over InP substrate bottlenecks. And there's even AXT direct confirmation of partnerships with $LITE and $COHR as the InP substrate supplier. AXT also stated $130m/quarter InP revenue capacity exiting 2027 (~$520m annualized) so that's a massive revenue inflection compared to previously. Now... the biggest question is: How much can AXT price hike? The substrates they make are just such a tiny part of the BOM... but can threaten hyperscaler buildouts with optics. So if they manage to price hike to $SNDK NAND degrees (which they can), then I think AXT could get re-rated a ton from here. But if they end up like Japanese ABF suppliers that are less willing to abuse their position, that's a different story. Will need to do more channel checks to see how that's coming along. But at the very least, I would argue there should be some valuation baseline just due to their critical importance (eg. upstream refinery ownerships, crucible processing, etc) + existing capacity revenue without hikes. TLDR: - Bottleneck thesis was at like ~$500m MC - Upside now comes from price hikes due to duopoly position + ownership of upstream bottlenecks in the InP substrate manufacturing process. (whi (Bullish)
  • 9/29–10/5 · 0 posts · Bull 0 / Bear 0
    No discussion
  • 9/22–9/28 · 0 posts · Bull 0 / Bear 0
    No discussion

Key views and how they evolved Newest first

AXTI Small capEarnings 10/29 Neutral2026-10-18 23:41 HKTOriginal post ↗

@StockSavvyShay lists the top 15 performers of 2026: $MRNA +639%, $SNDK +447%, $TWST +319%, $DELL +259%, $AXTI +215%, $MU +208%, $AEHR +200%, $PENG +192%, $MRVL +168%, $BE +155%, $AMD +147%, $INTC +143%, $LITE +124%, $OSCR +122%, $AAOI +117%.

See original

HERE ARE THE TOP 15 PERFORMERS OF 2026 1. $MRNA +639% 2. $SNDK +447% 3. $TWST +319% 4. $DELL +259% 5. $AXTI +215% 6. $MU +208% 7. $AEHR +200% 8. $PENG +192% 9. $MRVL +168% 10. $BE +155% 11. $AMD +147% 12. $INTC +143% 13. $LITE +124% 14. $OSCR +122% 15. $AAOI +117%

Image 1 ↗

Reasoning: Not tagged by analyst Specific

AXTI Small capEarnings 10/29 Bullish2026-10-10 21:46 HKTOriginal post ↗

I think almost everything about my $AXTI thesis from 2025 was validated? From AXT's position in the InP substrate bottleneck... Being able to threaten the hyperscaler buildout (per Reuters)... $IQE has been flagging this as a major risk, VPEC and Taiwan epiwafer foundries have been crying over InP substrate bottlenecks. And there's even AXT direct confirmation of partnerships with $LITE and $COHR as the InP substrate supplier. AXT also stated $130m/quarter InP revenue capacity exiting 2027 (~$520m annualized) so that's a massive revenue inflection compared to previously. Now... the biggest question is: How much can AXT price hike? The substrates they make are just such a tiny part of the BOM... but can threaten hyperscaler buildouts with optics. So if they manage to price hike to $SNDK NAND degrees (which they can), then I think AXT could get re-rated a ton from here. But if they end up like Japanese ABF suppliers that are less willing to abuse their position, that's a different story. Will need to do more channel checks to see how that's coming along. But at the very least, I would argue there should be some valuation baseline just due to their critical importance (eg. upstream refinery ownerships, crucible processing, etc) + existing capacity revenue without hikes. TLDR: - Bottleneck thesis was at like ~$500m MC - Upside now comes from price hikes due to duopoly position + ownership of upstream bottlenecks in the InP substrate manufacturing process. (whi

Image 1 ↗

Reasoning: Fundamentals · Medium term Specific

Fund flows or trade records mentioned in posts reflect only the account’s own claims, are marked “Per the post” and are unverified.

Open the interactive page (with chart)